Minimizing toxicity in breast irradiation

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–271.
   PubMed Web of Science ®Google Scholar
• Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241.
   PubMed Web of Science ®Google Scholar
• Litiere S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13:412–419.
   PubMed Web of Science ®Google Scholar
• Polgar C, Fodor J, Major T, et al. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013;108:197–202.
   PubMed Web of Science ®Google Scholar
• Strnad V, Ott OJ, Hildebrandt G, et al. 5-year results of accelerated partial breast irradiation using solo interstitial multicatheter brachythereapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016;387:229–238.
   PubMed Web of Science ®Google Scholar
• Shah C, Khwaja S, Badiyan S, et al. Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesis. Brachytherapy. 2013;12:278–284.
   PubMed Web of Science ®Google Scholar
• Olivotto IA, Whelan TJ, Parpia S, et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol. 2013;31:4038–4045.
   PubMed Web of Science ®Google Scholar
• Rabinovitch R, Moughan J, Vicini F, et al. Long-term update of NRG Oncology RTOG 0319: a phase 1 and 2 trial to evaluate 3-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I and II breast carcinoma. Int J Radiat Oncol Biol Phys. 2016;96:1054–1059.
   PubMedGoogle Scholar
• Livi L, Meattini I, Marrazzo L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51:451–463.
   PubMed Web of Science ®Google Scholar
• Coles C, Agarwal R, Ah-See ML, et al. Partial breast radiotherapy for women with early breast cancer: first results of local recurrence data for IMPORT LOW. European Cancer Organisation, European Breast Cancer Conference 10. Amsterdam, Netherlands. March 9-11, 2016.
   Google Scholar
• Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26:2085–2092.
   PubMed Web of Science ®Google Scholar
• Donovan E, Bleakley N, Denholm E, et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol. 2007;82:254–264.
   PubMed Web of Science ®Google Scholar
• Keller LM, Sopka DM, Li T, et al. Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience. Int J Radiat Oncol Biol Phys. 2012;84:881–887.
   PubMed Web of Science ®Google Scholar
• Shah C, Wobb J, Grills I, et al. Use of intensity modulated radiation therapy to reduce acute and chronic toxicities of breast cancer patients treated with traditional and accelerated whole breast irradiation. Pract Radiol Oncol. 2012;2:e45–51.
   Google Scholar
• Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–998.
   PubMed Web of Science ®Google Scholar
• Swanson T, Grills IS, Ye H. Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or locally advanced breast cancer. Am J Clin Oncol. 2013;36:24–30.
   PubMed Web of Science ®Google Scholar
• Korreman SS, Pederson AN, Aarup LR, et al. Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2006;65:1375–1380.
   PubMed Web of Science ®Google Scholar
• Ma CM, Ding M, Li JS, et al. A comparative dosimetric study on tangential photon beam, intensity-modulated radiation therapy (IMRT) and modulated electron radiotherapy (MERT) for breast cancer treatment. Phys Med Biol. 2003;48:909–924.
   PubMed Web of Science ®Google Scholar
• Kirby AM, Evans PM, Donovan EM, et al. Prone versus supine positioning for whole and partial breast radiotherapy: a comparison of non-target tissue dosimetry. Radiother Oncol. 2010;96:178–184.
   PubMed Web of Science ®Google Scholar
• Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy with invasive breast cancer of one centimeter or less. J Clin Oncol. 2002;20:4141–4149.
   PubMed Web of Science ®Google Scholar
• Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–1716.
   PubMed Web of Science ®Google Scholar
• Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation on women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382–2387.
   PubMed Web of Science ®Google Scholar
• Kunkler IH, Williams LJ, Jack WJ, et al. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015;16:266–273.
   PubMed Web of Science ®Google Scholar
• Solin LJ, Gray R, Hughes LL, et al. Surgical excision without radiation for ductal carcinoma in situ of the breast:12-year results from the ECOG-ACRIN E5194 study. J Clin Oncol. 2015;33:3938–3944.
   PubMed Web of Science ®Google Scholar
• McCormick B. RTOG 9804: a prospective randomized trial for “good risk” ductal carcinoma in situ (DCIS), comparing radiation (RT) to observation (OBS). J Clin Oncol. 2012;30(s):1004.
   Google Scholar
• Solin LJ, Gray R, Baehner FL, et al. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2013;105:701–710.
   PubMed Web of Science ®Google Scholar
• Rakovitch E, Nofech-Mozes S, Hanna W, et al. A population-based validation study of the DCIS score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Breast Cancer Res Treat. 2015;152:389–398.
   PubMed Web of Science ®Google Scholar
• Raldow AC, Sher D, Chen AP, et al. Cost effectiveness of the Oncotype DX DCIS score for guiding treatment of patient with ductal carcinoma in situ. J Clin Oncol. 2016 Sep 12. Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Liu FF, Shi W, Done SJ, et al. Identification of a low-risk luminal a breast cancer cohort that may not benefit from breast radiotherapy. J Clin Oncol. 2015;33:2035–2040.
   PubMed Web of Science ®Google Scholar